Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis
Liver International Jun 24, 2018
Kim D, et al. - Cross-sectional data from the National Health and Nutrition Examination Survey 1999-2002 was utilized in order to determine the impact of telomere length on nonalcoholic fatty liver disease and advanced fibrosis in a large nationally representative sample of American adults. Researchers determined the presence of advanced fibrosis by the nonalcoholic fatty liver disease fibrosis score, aspartate aminotransferase to platelet ratio index and FIB-4 score. The findings demonstrated that leucocyte telomere shortening was correlated with increased risk of advanced fibrosis in the setting of suspected nonalcoholic fatty liver disease independent of other known risk factors.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries